CLINICAL_TRIALS
trial_result
· 2012-02-17
Clinical Trial Update: Effect of Indacaterol on Inspiratory Capacity (IC) [Phase 3]
Summary
Phase 3 trial evaluating indacaterol's effect on inspiratory capacity in chronic obstructive pulmonary disease has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2012-02-17